Clincosm LogoSign in Get a demo

Refractory Malignant Solid Neoplasm

Showing 51 - 57 of 57
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Refractory Malignant Solid Tumor Trial in Shanghai (anti-MESO CAR T cells)

Recruiting
  • Refractory Malignant Solid Neoplasm
  • anti-MESO CAR T cells
  • Shanghai, China
    Department of Oncology, Ruijin Hospital
Sep 16, 2021

Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (FGFR Inhibitor

Completed
Has Results
  • Advanced Lymphoma
  • +5 more
  • FGFR Inhibitor AZD4547
  • Philadelphia, Pennsylvania
    ECOG-ACRIN Cancer Research Group
Jun 8, 2021

Recurrent Cutaneous Melanoma, Recurrent Lip and Oral Cavity Carcinoma, Recurrent Malignant Endocrine Tumor Trial in Houston

Recruiting
  • Recurrent Cutaneous Melanoma
  • +27 more
  • Cord Blood-derived Expanded Allogeneic Natural Killer Cells
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Apr 28, 2021

Childhood Solid Tumor, Recurrent Malignant Solid Tumor, Recurrent Primary CNS Tumor Trial in United States (Laboratory Biomarker

Completed
  • Childhood Solid Neoplasm
  • +4 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Birmingham, Alabama
  • +20 more
Apr 12, 2021

Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Nivolumab)

Completed
Has Results
  • Advanced Lymphoma
  • +5 more
  • Nivolumab
  • Philadelphia, Pennsylvania
    ECOG-ACRIN Cancer Research Group
Mar 15, 2021

Advanced Lymphoma, Advanced Malignant Solid Tumor, Ann Arbor Stage III B-Cell Non-Hodgkin Lymphoma Trial (Entinostat,

Withdrawn
  • Advanced Lymphoma
  • +16 more
  • (no location specified)
Sep 25, 2020

Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Dasatinib)

Withdrawn
  • Advanced Lymphoma
  • +5 more
  • Philadelphia, Pennsylvania
    ECOG-ACRIN Cancer Research Group
Jul 17, 2020